LUNG
Pulmonx Corp
$1.37
-3.52%
$57.9M
No data for this timeframe.
Vol
Market Cap$57.9M
Cap SizeMicro Cap
Analyst ConsensusStrong Buy (73%)
Inst. Holders47 funds
Inst. Value$21.9M
Inst. Activity7 buys / 3 sells
Insider Activity0B / 7S
Insider Net $-$46.0K
SEC Reports7
Press Releases1
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0001127537·Prev Close $1.42
Recent Activity
Jun 9, 2026
SEC
Four Pulmonx insiders, including the CEO and General Counsel, sold a total of $34K in shares over a three-day window, wh
CLUSTER — Impact 2/10
Jun 9, 2026
SEC
Pulmonx Corp (LUNG) insiders filed 6 trades in an 8-day window: 4 non-cash grant/withhold events (zero economic value) p
CLUSTER — Impact 4/10
Jun 5, 2026
Insider
Burns Thomas William was granted 40,000 shares
Director
Jun 5, 2026
Insider
Ferrari Richard was granted 40,000 shares
Director
Jun 5, 2026
Insider
Florin Daniel P was granted 40,000 shares
Director
Apr 22, 2026
SEC
Pulmonx Corp filed a definitive proxy statement (DEFA14A) for an upcoming shareholder meeting, detailing proposals relat
DEFA14A — Impact 3/10
Inst.
BANK OF AMERICA CORP — ADD
1,166,826 shares ($1.5M)
Inst.
Centiva Capital, LP — DOUBLED
153,882 shares ($198.5K)
Price Targets
$3.40
+148.2% upside
Strong Buy
Current $1.37
Low $2.50
Median $3.00
High $5.00
5 analysts
$2.50
$5.00
Analyst Ratings
3Strong Buy
5Buy
3Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Apr 30, 2026 | D. Boral Capital | MAINTAIN | Buy → Buy |
| Mar 5, 2026 | Canaccord Genuity | MAINTAIN | Buy → Buy |
| Mar 5, 2026 | D. Boral Capital | MAINTAIN | Buy → Buy |
| Feb 20, 2026 | D. Boral Capital | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.28 ▼ -1.2% | $-0.29 — $-0.27 | 26% YoY | 5 |
| Next Q | $-0.29 ▼ -0.9% | $-0.30 — $-0.27 | 16% YoY | 5 |
| Current FY | $-1.14 | $-1.18 — $-1.10 | 14% YoY | 5 |
| Next FY | $-1.04 ▼ -3.4% | $-1.15 — $-0.89 | 9% YoY | 5 |
Latest Reports
NEUTRAL
CLUSTER
2/10
Four Pulmonx insiders, including the CEO and General Counsel, sold a total of $34K in shares over a three-day window, wh
Jun 9, 2026
NEUTRAL
CLUSTER
4/10
Pulmonx Corp (LUNG) insiders filed 6 trades in an 8-day window: 4 non-cash grant/withhold events (zero economic value) p
Jun 9, 2026
MIXED
Press
6/10
Pulmonx reported mixed financial results for 2025, with full-year revenue up 8% to $90.5 million but Q4 revenue down 5%
Mar 4, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| MORGAN STANLEY | $5.2M | — |
| BlackRock, Inc. | $3.4M | — |
| ExodusPoint Capital Management, LP | $2.5M | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.1M | — |
| BANK OF AMERICA CORP | $1.5M | ADD |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 5, 2026 | Burns Thomas | A | $0.00 |
| Jun 5, 2026 | Ferrari Richard | A | $0.00 |
| Jun 5, 2026 | Florin Daniel | A | $0.00 |
| Jun 5, 2026 | Melenikiotou Georgia | A | $0.00 |
| Jun 5, 2026 | Sullivan Tiffany | A | $0.00 |
47 institutional holders with $21.9M total value (16,972,498 shares) as of 2026-Q1. Top holders: MORGAN, BlackRock,, ExodusPoint. Net buying activity: 7 institutions added/increased vs 3 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | MORGAN STANLEY | 3,993,562 | $5.2M | 23.5% | — |
| 2 | BlackRock, Inc. | 2,661,607 | $3.4M | 15.7% | — |
| 3 | ExodusPoint Capital Management, LP | 1,943,834 | $2.5M | 11.4% | — |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 1,634,264 | $2.1M | 9.6% | — |
| 5 | BANK OF AMERICA CORP /DE/ | 1,166,826 | $1.5M | 6.9% | ADD +60.3% |
| 6 | DEUTSCHE BANK AG\ | 1,163,678 | $1.5M | 6.8% | — |
| 7 | STATE STREET CORP | 809,116 | $1.0M | 4.8% | — |
| 8 | BARCLAYS PLC | 683,435 | $881.6K | 4.0% | DOUBLED +161.6% |
| 9 | VANGUARD PORTFOLIO MANAGEMENT LLC | 604,455 | $779.7K | 3.6% | — |
| 10 | D. E. Shaw & Co., Inc. | 335,074 | $432.2K | 2.0% | TRIM -28.9% |
| 11 | RENAISSANCE TECHNOLOGIES LLC | 320,300 | $413.2K | 1.9% | ADD +32.4% |
| 12 | VANGUARD FIDUCIARY TRUST CO | 281,248 | $362.8K | 1.7% | — |
| 13 | GOLDMAN SACHS GROUP INC | 223,450 | $288.3K | 1.3% | — |
| 14 | Centiva Capital, LP | 153,882 | $198.5K | 0.9% | DOUBLED +729.8% |
| 15 | DIMENSIONAL FUND ADVISORS LP | 141,920 | $182.7K | 0.8% | TRIM -51.2% |
| 16 | ALLIANCEBERNSTEIN L.P. | 52,200 | $115.4K | 0.5% | — |
| 17 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 89,069 | $114.9K | 0.5% | — |
| 18 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 82,200 | $106.0K | 0.5% | — |
| 19 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 71,319 | $92.0K | 0.4% | TRIM -65.6% |
| 20 | Nuveen, LLC | 69,108 | $89.2K | 0.4% | TRIM -65.3% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | ADD | 727,799 | 1,166,826 | +60.3% | $1.5M | 2026-Q1 |
| Centiva Capital, LP | DOUBLED | 18,545 | 153,882 | +729.8% | $198.5K | 2026-Q1 |
| FMR LLC | TRIM | 75,202 | 48,222 | -35.9% | $62.2K | 2026-Q1 |
| Cerity Partners LLC | DOUBLED | 12,364 | 28,836 | +133.2% | $37.2K | 2026-Q1 |
| CWM, LLC | DOUBLED | 3,830 | 17,719 | +362.6% | $22.9K | 2026-Q1 |
| TUDOR INVESTMENT CORP ET AL | TRIM | 22,912 | 11,028 | -51.9% | $14.2K | 2026-Q1 |
| Russell Investments Group, Ltd. | TRIM | 12,574 | 3,892 | -69.0% | $5.0K | 2026-Q1 |
| PNC FINANCIAL SERVICES GROUP, INC. | DOUBLED | 68 | 3,004 | +4317.6% | $3.9K | 2026-Q1 |
| Allworth Financial LP | DOUBLED | 19 | 491 | +2484.2% | $634.00 | 2026-Q1 |
| NISA INVESTMENT ADVISORS, LLC | DOUBLED | 214 | 465 | +117.3% | $600.00 | 2026-Q1 |
| BANK OF AMERICA CORP /DE/ | ADD | 479,023 | 727,799 | +51.9% | $1.6M | 2025-Q4 |
| D. E. Shaw & Co., Inc. | TRIM | 789,249 | 561,266 | -28.9% | $1.2M | 2025-Q4 |
| DIMENSIONAL FUND ADVISORS LP | TRIM | 344,467 | 168,200 | -51.2% | $372.0K | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 46,456 | 132,770 | +185.8% | $293.4K | 2025-Q4 |
| FMR LLC | NEAR_EXIT | 2,174,358 | 75,202 | -96.5% | $166.2K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 23,741 | 47,580 | +100.4% | $105.2K | 2025-Q4 |
| FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND | TRIM | 76,253 | 40,000 | -47.5% | $88.4K | 2025-Q4 |
| Jain Global LLC | ADD | 18,766 | 30,566 | +62.9% | $67.6K | 2025-Q4 |
| TUDOR INVESTMENT CORP ET AL | NEAR_EXIT | 211,121 | 22,912 | -89.1% | $50.6K | 2025-Q4 |
| Russell Investments Group, Ltd. | ADD | 7,007 | 12,574 | +79.4% | $27.8K | 2025-Q4 |
| NISA INVESTMENT ADVISORS, LLC | TRIM | 639 | 214 | -66.5% | $473.00 | 2025-Q4 |
| CWM, LLC | DOUBLED | 1,477 | 3,830 | +159.3% | $8.00 | 2025-Q4 |
| FMR LLC | TRIM | 4,261,368 | 2,174,358 | -49.0% | $3.5M | 2025-Q3 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | ADD | 930,557 | 1,264,233 | +35.9% | $2.0M | 2025-Q3 |
| D. E. Shaw & Co., Inc. | ADD | 489,880 | 789,249 | +61.1% | $1.3M | 2025-Q3 |
10 unique insiders with 13 transactions. Net insider value: -$46.0K ($0.00 bought, $46.0K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Burns Thomas William | Director | AWARD | 40,000 | — | — |
| Jun 5, 2026 | Ferrari Richard | Director | AWARD | 40,000 | — | — |
| Jun 5, 2026 | Florin Daniel P | Director | AWARD | 40,000 | — | — |
| Jun 5, 2026 | Melenikiotou Georgia | Director | AWARD | 40,000 | — | — |
| Jun 5, 2026 | Sullivan Tiffany | Director | AWARD | 40,000 | — | — |
| Jun 5, 2026 | Mead Dana G Jr. | Director | AWARD | 40,000 | — | — |
| Jun 2, 2026 | French Glendon E. III | President and CEO | SELL | 13,511 | $1.57 | $21.2K |
| Jun 1, 2026 | Lehman David Aaron | GENERAL COUNSEL | SELL | 3,876 | $1.54 | $6.0K |
| Jun 1, 2026 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | SELL | 1,778 | $1.54 | $2.7K |
| Jun 1, 2026 | Radhakrishnan Srikanth | Chief Science &Techn. Officer | SELL | 2,691 | $1.54 | $4.1K |
| Jun 1, 2026 | French Glendon E. III | President and CEO | SELL | 4,171 | $1.54 | $6.4K |
| Mar 2, 2026 | Lehman David Aaron | GENERAL COUNSEL | SELL | 1,163 | $1.43 | $1.7K |
| Mar 2, 2026 | French Glendon E. III | President and CEO | SELL | 2,708 | $1.43 | $3.9K |
7 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 1 mixed, 5 neutral. Avg impact: 3.9/10.
NEUTRAL
CLUSTER
2/10
Four Pulmonx insiders, including the CEO and General Counsel, sold a total of $34K in shares over a
Jun 9, 2026
NEUTRAL
CLUSTER
4/10
Pulmonx Corp (LUNG) insiders filed 6 trades in an 8-day window: 4 non-cash grant/withhold events (ze
Jun 9, 2026
NEUTRAL
DEFA14A
3/10
Pulmonx Corp filed a definitive proxy statement (DEFA14A) for an upcoming shareholder meeting, detai
Apr 22, 2026
NEUTRAL
PRESS-RELEASE
3/10
Pulmonx Corporation announced it will release Q1 2026 financial results on April 29, 2026, with a co
Apr 15, 2026
BEARISH
8-K
7/10
Pulmonx Corp entered into a $60 million senior secured term loan facility with Perceptive, consistin
Mar 5, 2026
NEUTRAL
CLUSTER
2/10
Two corporate insiders at Pulmonx Corp, including CEO Glendon French, sold shares in the open market
Mar 5, 2026
MIXED
8-K
6/10
Pulmonx reported mixed financial results for Q4 and full year 2025, with full-year revenue up 8% to
Mar 4, 2026
Current analyst consensus: Buy (73% buy). Based on 11 analysts: 3 strong buy, 5 buy, 3 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$3.40 mean target
+148.2% upside
Strong Buy (3.00)
$2.50 Low
$5.00 High
| Metric | Value |
|---|---|
| Current Price | $1.37 |
| Target Low | $2.50 |
| Target Mean | $3.40 |
| Target Median | $3.00 |
| Target High | $5.00 |
| # Analysts | 5 |
| Recommendation | Strong Buy (3.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.28 | $-0.29 | $-0.27 | 26.3% | -1.2% | 3↑ 0↓ | $0.0B | -6.1% | 5 |
| Next Q 2026-09-30 |
$-0.29 | $-0.30 | $-0.27 | 15.9% | -0.9% | 2↑ 1↓ | $0.0B | 5.4% | 5 |
| Current FY 2026-12-31 |
$-1.14 | $-1.18 | $-1.10 | 14.1% | -0.5% | 4↑ 0↓ | $0.1B | 0.3% | 5 |
| Next FY 2027-12-31 |
$-1.04 | $-1.15 | $-0.89 | 8.6% | -3.4% | 3↑ 0↓ | $0.1B | 8.0% | 5 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.280 | |
| 7d ago | $-0.282 | +0.002 |
| 30d ago | $-0.277 | -0.003 |
| 60d ago | $-0.277 | -0.003 |
| 90d ago | $-0.332 | +0.052 |
2 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Apr 30, 2026 | D. Boral Capital | MAINTAIN | Buy | Buy |
| Mar 5, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| Mar 5, 2026 | D. Boral Capital | MAINTAIN | Buy | Buy |
| Feb 20, 2026 | D. Boral Capital | MAINTAIN | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 5 | 3 | 0 | 0 | 73% | |
| May 1, 2026 | 3 | 6 | 3 | 0 | 0 | 75% | |
| Apr 1, 2026 | 3 | 6 | 3 | 0 | 0 | 75% | |
| Mar 1, 2026 | 3 | 6 | 3 | 0 | 0 | 75% | |
| Feb 1, 2026 | 3 | 6 | 3 | 0 | 0 | 75% | |
| Jan 1, 2026 | 3 | 6 | 3 | 0 | 0 | 75% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 1, 2026
activist
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
<p align="justify">REDWOOD CITY, Calif., June 01, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (the “Company” or “Pulmonx”), a global
Apr 29, 2026
earnings_calendar
LUNG Q1 2026 Earnings After Market Close — 2026-04-29
Apr 15, 2026
earnings
Pulmonx to Report First Quarter 2026 Financial Results on April 29, 2026
<p>REDWOOD CITY, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive tr
Mar 4, 2026
earnings
Pulmonx Reports Fourth Quarter and Full Year 2025 Financial Results
<p>REDWOOD CITY, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in mini
Mar 4, 2026
other
Pulmonx Announces Closing of up to $60 Million Credit Facility
Refinancing Strengthens Capital Structure by Extending Debt Maturity and Providing Access to Additional Undrawn Capital <pre>Refinancing Strengthens C
Mar 4, 2026
earnings_calendar
LUNG Q4 2025 Earnings After Market Close — 2026-03-04
Feb 25, 2026
earnings_calendar
LUNG Q4 2025 Earnings After Market Close — 2026-02-25